---
title: "CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CDNA Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284934411.md"
description: "CareDx, Inc. announced the award of inducement grants under Nasdaq Listing Rule 5635(c)(4) for 23 new employees, totaling 63,856 restricted stock units (RSUs). The RSUs will vest over four years, with 25% vesting on the first anniversary and the remainder vesting quarterly thereafter, contingent on continued employment. This announcement aligns with the company's 2019 and 2025 Inducement Equity Incentive Plans."
datetime: "2026-05-01T12:01:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284934411.md)
  - [en](https://longbridge.com/en/news/284934411.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284934411.md)
---

# CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CDNA Stock News

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the award of inducement grants.

On April 30, 2026, as an inducement material to acceptance of employment with CareDx, 23 new employees were awarded restricted stock units (RSUs) for an aggregate of 63,856 shares of common stock.

The RSU awards were made pursuant to the Company’s 2019 and 2025 Inducement Equity Incentive Plans in accordance with Nasdaq Listing Rule 5635(c)(4).

The RSUs will vest over four years, with 25% of the RSUs vesting on the first anniversary of each employee’s vesting commencement date, and 1/16th of the RSUs vesting on each date that is three (3) months thereafter subject to each employee’s continued service through each vesting date.

CareDx is providing this information in accordance with Nasdaq Listing Rule 5635(c)(4).

View source version on businesswire.com: https://www.businesswire.com/news/home/20260501877613/en/

CareDx  
Media Contacts  
Natasha Moshirian Wagner  
nwagner@caredx.com

Investor Relations  
Caroline Corner  
investor@caredx.com

Source: CareDx, Inc.

### Related Stocks

- [CDNA.US](https://longbridge.com/en/quote/CDNA.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md)

## Related News & Research

- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Guardant Health Says US FDA Approved Liquid Biopsy Test](https://longbridge.com/en/news/287069625.md)
- [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)
- [Resona Asset Management Co. Ltd. Cuts Position in Danaher Corporation $DHR](https://longbridge.com/en/news/286897088.md)
- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)